| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.26 | 4e-11 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-09 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.56 | 1e-07 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-06 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-06 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.21 | 3e-06 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-06 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.16 | 4e-06 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.13 | 2e-05 |